VRNA (Verona Pharma plc) Earnings per share growth rate in current year

Official company branding of Verona Pharma plc (VRNA)

Verona Pharma plc (VRNA) management has concentrated resources on the aggressive market launch of its innovative product, securing capitalization through robust financing. The annual EPS percentage change demonstrates current volatility, where 95.90 reflects the metric's baseline level. The company is implementing ESG principles into the production of respiratory treatments, although the pace of COPD therapy recognition remains the primary risk factor for earnings.

VRNA (Verona Pharma PLC) Net earnings per share growth this year history from 07/04/2022 to 10/18/2025

Analytical breakdowns and data insights for company Verona Pharma (VRNA)

- business market valuation indicators:
Basic company analysis:VRNA Verona Pharma Inc.
Signature product of veronapharma.com

The assessment of the asset's operational strength is based on earnings per share (EPS) dynamics, where annual EPS growth measures the actual pace of fundamental business scaling by filtering out market noise. For Verona Pharma plc (VRNA), this trend is critical, as it allows for an evaluation of profit sustainability amid geopolitical risks that hinder international clinical trials and component logistics.

Main competitors

Earnings per share growth rate in current year Haleon Corp (HLN)|KVUE (Kenvue Inc) - Earnings growth in current year|Earnings per share growth rate in current year jyongbio.com MENS|Earnings per share growth in current year Ligand (LGND)|AMRX (Amneal) - Earnings per share increase in current year|Earnings per share growth in current year Perrigo PRGO|Earnings growth in current year Alvotech Biopharmaceuticals ALVO|liquidia.com - Earnings growth in current year|GLPG - Earnings growth in current year|ANIP: Earnings growth in current year|Earnings per share growth this year MNKD|AMPH (Amphastar) - Earnings growth in current year|Pacira Corp (PCRX) - Expected net earnings per share growth this year|Earnings per share growth in current year ARS Pharma (SPRY)|Earnings growth in current year Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Net earnings per share growth this year|Earnings per share increase in current year SCPH|Tectonic Therapeutic Inc. - Earnings growth in current year|Earnings per share trend in current year TNXP|SXTC (China SXT Pharmaceuticals) - Net earnings per share growth this year|Eupraxia Pharmaceuticals (EPRX) - Earnings growth in current year|Earnings per share growth in current year BioHarvest Sciences, Inc.|EXOZ: Earnings per share increase in current year|Earnings growth in current year ORMP|ENTX - Earnings per share growth rate in current year|Earnings per share growth in current year MindWalk Holdings, Inc. HYFT|Earnings growth in current year abvcpharma.com ABVC|CPIX - Earnings per share growth in current year|Earnings per share trend in current year QNTM|FGEN (FibroGen Corporation) - Net earnings per share growth this year|Net earnings per share growth this year Telomir Pharma|Net earnings per share growth this year RANI|Earnings per share growth rate in current year synergychc.com SNYR|Earnings per share growth in current year Rallybio Corp (RLYB)|LEXX - Earnings per share growth rate in current year|Pulmatrix Inc - Net earnings per share growth this year|Earnings per share increase in current year PTHL|Aptorum Group Ltd - Earnings growth in current year|Expected net earnings per share growth this year Lyra Therapeutics LYRA|IBO: Earnings growth in current year|TNFA (TNF Pharma) - Earnings per share growth in current year|Earnings per share growth in current year cbdmd.com|Earnings per share growth this year PRFX (PainReform Corp)|Earnings growth in current year CYTO|Net earnings per share growth this year Lipella Pharmaceuticals LIPO|Earnings per share growth in current year OptiNose OPTN|Pieris Pharmaceuticals Inc - Earnings per share growth in current year|Procaps Group Corp - Earnings growth in current year|Expected net earnings per share growth this year Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN (SLRN) - Earnings growth in current year|Earnings per share growth in current year TFF Pharmaceuticals